An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on an online forum reported increasing their Wegovy dose from 1.0 mg to 1.7 mg and said they haven’t noticed any difference after six weeks. They expected more side effects (nausea, gas) like when they went from 0.5 to 1.0 mg, and they haven’t lost any weight in those six weeks. They also said they’re down 10 kg (about 22 pounds) since starting Wegovy 18 months ago and hope to lose another 8–10 kg. Wegovy’s active ingredient is semaglutide. That’s a synthetic version of a hormone your gut makes after you eat, which helps tell your brain you’re full and slows how fast your stomach empties. In plain terms, it often reduces appetite and can make food less appealing, which helps many people eat less and lose weight over time. Doctors prescribe it at gradually increasing doses to balance benefits and side effects. What this single report shows is very limited. It’s one person’s experience on a forum, not a clinical trial. People often see weight changes at different speeds; some lose rapidly after a dose increase, others see delayed or little change. Side effects also vary—some get stronger stomach upset when increasing the dose, others don’t. Six weeks is a short window; clinical studies usually look at months to a year to judge steady weight-loss effects. So this anecdote can tell you that variability happens, but it doesn’t prove how effective 1.7 mg is in general. Why that matters to a regular person is practical. If you or someone you know is using Wegovy or considering dose changes, expect that responses differ. A lack of quick change after a dose increase isn’t rare and doesn’t automatically mean the drug isn’t working long-term. Also, the fact the person kept weight off overall (10 kg over 18 months) is a reminder that even if progress slows, many people maintain and continue to improve gradually. Caveats and risks: an online post doesn’t track medical history, other medications, diet, exercise, or underlying conditions that affect weight. Semaglutide can cause nausea, vomiting, diarrhea, constipation, and sometimes more serious issues; it’s important to discuss dose changes with a prescribing clinician. Don’t assume everyone will feel side effects or see weight loss at the same pace. Semaglutide for weight loss is prescription-only and should be used under medical supervision, especially if you have pancreatitis, certain thyroid conditions, or are pregnant or trying to become pregnant. Bottom line: One person’s lack of change after increasing Wegovy to 1.7 mg shows that individual responses vary and that six weeks is a short time to judge; talk to your prescriber before changing doses or drawing conclusions.
Source: r/Semaglutide